Reduction in Arterial Wall Strain With Aggressive Lipid-Lowering Therapy in Patients With Carotid Artery Disease
スポンサーリンク
概要
- 論文の詳細を見る
Background: Inflammation and biomechanical factors have been associated with the development of vulnerable atherosclerotic plaques. Lipid-lowering therapy has been shown to be effective in stabilizing them by reducing plaque inflammation. Its effect on arterial wall strain, however, remains unknown. The aim of the present study was to investigate the role of high- and low-dose lipid-lowering therapy using an HMG-CoA reductase inhibitor, atorvastatin, on arterial wall strain. Methods and Results: Forty patients with carotid stenosis >40% were successfully followed up during the Atorvastatin Therapy: Effects on Reduction Of Macrophage Activity (ATHEROMA; ISRCTN64894118) Trial. All patients had plaque inflammation as shown by intraplaque accumulation of ultrasmall super paramagnetic particles of iron oxide on magnetic resonance imaging at baseline. Structural analysis was performed and change of strain was compared between high- and low-dose statin at 0 and 12 weeks. There was no significant difference in strain between the 2 groups at baseline (P=0.6). At 12 weeks, the maximum strain was significantly lower in the 80-mg group than in the 10-mg group (0.0850.033 vs. 0.1690.084; P=0.001). A significant reduction (26%) of maximum strain was observed in the 80-mg group at 12 weeks (0.0180.02; P=0.01). Conclusions: Aggressive lipid-lowering therapy is associated with a significant reduction in arterial wall strain. The reduction in biomechanical strain may be associated with reductions in plaque inflammatory burden. (Circ J 2011; 75: 1486-1492)
論文 | ランダム
- 挑戦する心(5)「遊びは文化」の意味を求めて--株式会社タカラ 社長 佐藤慶太
- インタビュー 佐藤慶太・タカラ社長「世界の玩具マーケットでタカラは圧倒的優位にある」 (特集 「遊び心」でおもちゃを超える タカラの発想力)
- 佐藤慶治氏(元ハワイ中央太平洋銀行頭取・会長)に聞く : 2001年9月10日,ハワイ日本文化センターにて
- 同一母系家系内における mtDNA Length Heteroplasmy の多様性
- 大都市郊外住民の応急仮設住宅希望の分析